entertainment -WSS

entertainment

author：focus 2025-10-01 02:14:30 - browse：1845

Steward CEO Ralph de la Torre, pictured here in 2010, has led the company since its inception. Wendy Maeda/The Boston Globe

Steward Health Care, which once trumpeted its community hospital system as a low-cost alternative to Boston’s medical goliaths before expanding nationally and falling into a deep financial crisis, filed for bankruptcy protection early Monday morning.

Under Chapter 11 of the US bankruptcy code, Steward will become a “debtor in possession,” continuing to operate its 32 hospitals in eight states while it seeks to restructure its debt under court supervision. Steward has eight hospitals in eastern Massachusetts, though its Norwood Hospital remains closed following a flood.

“Steward does not expect any interruptions in its day-to-day operations, which will continue in the ordinary course throughout the [bankruptcy] process,” it said in a news release posted at 3:27 a.m. “Steward’s hospitals, medical centers and physician’s offices are open and continuing to serve patients and the broader community and our commitment to our employees will not change.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Boston Scientific acquires urology company Axonics for $3.7 billion

WSS

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Gene therapy denied for Afghan refugee whose father aided U.S.

The explosion of genetic testing requires a new approach

Ascension's ugly legal battle over care for poor patients in Texas

How climate

FDA warns J&J's Abiomed: We will regulate your software

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare Advantage overpayments discussion gets experts fired up

23andMe had bad news about my health. I wish a person had delivered it

STAT Readout Newsletter: Today's biggest biotech updates

Medical records are filled with copy

STAT Readout Newsletter: Today's biggest biotech updates

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Arena BioWorks launches in Cambridge to speed drug discovery

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA warns J&J's Abiomed: We will regulate your software

knowledge

JPM pitch from hospitals? Revenue streams outside of patient care

UnitedHealth’s board chair also owns a personal investment firm

NIH confirmation hearing shows politicization of research

Will Ozempic

Life science postdocs should get big pay hike, NIH panel says

Hospital price transparency does save money, advocate argues

hotspot

focus

knowledge

Wikipedia